Navigation Links
Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
Date:5/8/2013

SAN DIEGO, May 8, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company's management will present a corporate overview at the following investment conferences during the month of May:

  • Bank of America Merrill Lynch 2013 Health Care Conference at the Encore at the Wynn Hotel in Las Vegas on Wednesday, May 15, 2013 at 2:20pm Pacific Time (5:20pm Eastern Time).
  • UBS Global Healthcare Conference 2013 at the Sheraton New York Hotel in New York City on Tuesday, May 21 at 2:00pm Eastern Time (11:00am Pacific Time).
  • Deutsche Bank's 38th Annual Health Care Conference at the Westin Boston Waterfront Hotel in Boston on Thursday, May 30, 2013 at 11:20am Eastern Time (8:20am Pacific Time).

Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section.  A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. For more information about Cadence, please visit www.cadencepharm.com.

Contacts:

William R. LaRue

SVP, CFO     
'/>"/>


SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
2. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
3. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
4. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
5. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
6. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Leerink Swann Global Healthcare Conference In New York City On February 13, 2013
7. Cadence Pharmaceuticals Estimates Fourth Quarter 2012 Net Product Revenue and Provides Full Year 2013 Revenue Guidance
8. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
9. Cadence Pharmaceuticals to Host Analyst and Investor Day
10. Cadence to Open Finished Medical Device Facility
11. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Piper Jaffray 24th Annual Healthcare Conference In New York City On November 28, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 BioCorRx, Inc. ( BICX ... is a healthcare solutions organization, which focuses solely ... $22 billion in the U.S. alone. The Company created a ... in a specially compounded form for outpatient surgical implantation. The ... and New Zealand ) to the specially ...
(Date:3/27/2015)... CHAPEL HILL, N.C. , March 27, 2015 /PRNewswire/ ... function is essential to meeting challenges in clinical development, ... and face tighter regulations, the Medical Affairs function is ... charted by mature markets. According to ... market study participants have a group dedicated to Medical ...
(Date:3/27/2015)... , March 27, 2015  The quality function ... description: ensure products meet quality standards at every stage ... escalating regulations, quality leaders also have the challenge of ... Those who don,t effectively balance these priorities ... well as marketplace failure and regulatory scrutiny. ...
Breaking Medicine Technology:Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S. 2Medical Affairs Capabilities Expanding in Emerging Marketplaces 2New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2
... YORK, May 25, 2011 Amgen (NASDAQ: ... ) today announced new results from multiple studies of ... efficacy and safety profile of ENBREL, the most prescribed ... abstracts across four indications, including moderate-to-severe rheumatoid arthritis (RA), ...
... ST. LOUIS, May 25, 2011 Building on its ... Materials Science , a strategic growth initiative of ... the establishment of a permanent endowment through the Materials ... Researcher Award. Intended to honor individuals who have ...
Cached Medicine Technology:Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions 2Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions 3Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions 4Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions 5Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions 6Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions 7Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions 8Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions 9Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions 10Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions 11Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions 12Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions 13Aldrich Materials Science Endows New Materials Research Society Mid-Career Researcher Award 2Aldrich Materials Science Endows New Materials Research Society Mid-Career Researcher Award 3
(Date:3/28/2015)... Rocket Pure , a manufacturer of natural body care ... natural sunscreen. They are offering the sunscreen in both ... with a bonus lip balm sunscreen. , The new products ... Click to see the natural sunscreen on Amazon . , ... with non-nano zinc oxide and provides broad-based protection against UVA ...
(Date:3/28/2015)... March 28, 2015 Coffee could not only ... protect you from gum disease, researchers have found. , They ... disease. , Coffee contains antioxidants. Antioxidants fight gum disease. Does ... researchers at Boston Univ. Henry M. Goldman School of Dental ... August 2014 issue of the Journal of Periodontology. , “This ...
(Date:3/28/2015)... Could genetic code determine someone’s coffee habit? ... by researchers at the Harvard T.H. Chan School of ... the Coffee and Caffeine Genetics Consortium and published ... the study—one of several recent HSPH investigations of the ... than 120,000 regular coffee drinkers of European and African ...
(Date:3/28/2015)... "Necrorun" was featured on NewsWatch as part of ... latest and coolest applications on the market for iOS, ... and technology expert, conducted the app review and shared ... game with knights, nature, and peasants. , The ... to Eurogamer. The popularity of these games grew over ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Take a ... system kicks into action. Acids tumble into the stomach, ... a faulty valve-like structure lets these acids run amok, ... an extremely common symptom. More than 60 million Americans ... slides examine where heartburn starts, and how it can ...
Breaking Medicine News(10 mins):Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2
... SOA integration, and Complex-Event Processing (CEP) Technologies Unified ... 30 First Choice Professionals, LLC., today announced ... TIBX ), to provide healthcare organizations with ... solution. FCP,s renowned healthcare integration group will combine ...
... Inc. (NYSE: IMA ), a global leader in ... through the merger of rapid diagnostics and health management, announced ... C. DIFF QUIK CHEK COMPLETE (TM) rapid test as ... difficile associated disease (CDAD). This follows TECHLAB(R), Inc.,s recent ...
... Sheets: IMMB) has completed a reverse merger with a ... a 100 to 1 reverse split of stock. ... the total number of issued and outstanding shares to ... IMMB.Immunotech Laboratories, Inc. has indefinite licensing rights of the ...
... at a rate not seen in more than twenty years, creating ... insurance for small business is being called a top priority at ... and (NFIB) and America,s Health Insurance Plans (AHIP). , ... ...
... MONDAY, March 30 (HealthDay News) -- Babies who gain weight ... more prone to obesity as toddlers, Harvard researchers report. , ... much younger," said study author Dr. Elsie M. Taveras. "Even ... start guiding parents about how to prevent rapid weight gain ...
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today ... Annual Meeting of Stockholders. Over the past several months, ... independent directors, engaged in a rigorous process to identify ... the Board strongly believes will best serve the interests ...
Cached Medicine News:Health News:First Choice Professionals and TIBCO Announce Strategic Partnership to Advance Healthcare Integration 2Health News:Inverness Medical Innovations Launches New FDA Cleared C. DIFF QUIK CHEK COMPLETE(TM) Rapid Test 2Health News:Inverness Medical Innovations Launches New FDA Cleared C. DIFF QUIK CHEK COMPLETE(TM) Rapid Test 3Health News:Inverness Medical Innovations Launches New FDA Cleared C. DIFF QUIK CHEK COMPLETE(TM) Rapid Test 4Health News:Immunotech Completes Merger Acquisition 2Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 2Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 3Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 4Health News:Rapid Infant Weight Gain Linked to Childhood Obesity 2Health News:Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders 2Health News:Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders 3Health News:Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders 4
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
... eye provides stability for contact lenses during ... tabs that are precisely positioned to provide ... sutures. They are constructed from implant grade ... and are compatible with all Volk indirect ...
... glass technologies and designs, the Digital ... views of the mid and far ... will provide image quality previously unattainable ... examination for more detailed and comprehensive ...
Latex agglutination slide test for the qualitative or quantitative determination of Cryptococcus neoformans antigen in CSF and serum....
Medicine Products: